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MOLECULAR CHARACTERISATION OF VANCOMYCIN RESISTANT 
ENTEROCOCCUS 
 
ABSTRACT 
BACKGROUND 
 The emergence of Enterococcus species as a causative agent of Health care 
associated infections and acquired resistance to commonly used antibiotics, pose a 
great challenge to the clinicians. Vancomycin Resistant Enterococci pose an emerging 
problem in hospitals which significantly contributing to patient morbidity and 
mortality. The present study was undertaken to determine the prevalence, risk factors, 
speciation, antimicrobial resistance, biofilm formation and phenotypic with genotypic 
characterization of Vancomycin Resistant Enterococci isolated from patients attending  
Rajiv Gandhi Government General Hospital, Chennai. 
 
MATERIALS AND METHODS 
 One hundred patients with clinical diagnosis of various infections from whom 
Enterococci were isolated from appropriate specimens were included in the study. The 
Enterococci were phenotypically characterised by standard microbiological 
techniques. The antimicrobial susceptibility pattern of all isolates including 
vancomycin resistant Enterococci were studied. Vancomycin resistance  among the 
Enterococci were detected  by  screening tests namely vancomycin disc diffusion test  
and vancomycin screen agar which was confirmed by determination of Minimal 
Inhibitory Concentration(MIC) by Microbroth dilution assay. All the VRE isolates 
were tested with third line supplemental drugs teicoplanin and linezolid. Genotyping 
of VRE isolates were carried out by Polymerase Chain Reaction (PCR). 
 
RESULTS 
 Enterococci (n=100) isolated from various clinical specimens of patients 
diagnosed with infections -UTI (77%) including 29% of CAUTI,  blood stream 
infections(14%) including 35.7% of CLABSI, SSI (6%) , ASOM(1%), Suppurative 
lymphadenitis (1%) and biliary tract infection (1%), were speciated phenotypically. 
The predominant species was E.faecalis (72%) followed by E.faecium (19%), 
E.dispar (8%) and E.durans (1%). On antimicrobial susceptibility testing for urinary 
isolates 93% of Enterococcus faecalis and 92% of Enterococcus faecium were found 
to be susceptible to Vancomycin and 82% and 77% of E.faecalis and E.faecium 
respectively were susceptible to Nitrofurantoin. The Vancomycin resistance was 
observed to be 8% among the Enterococci in the study. E.faecium exhibited more 
resistance to vancomycin than E.faecalis i.e 10.5% of E.faecium and 8.3% of 
E.faecalis were vancomycin resistant. All the VRE were sensitive to Linezolid and 
Quinupristin-dalfopristin (Q/D). Genotypic characterisation of VRE isolates 
confirmed the presence of van A gene in all. Detection of biofilm by standard 
techniques revealed the presence of biofilm in 67% of enterococci, among which 17% 
were strong producers and 50% were moderate producers. Mortality rate in the study 
population was 25%.  
 
CONCLUSION 
 This study demonstrates an increase in the prevalence of Enterococcal 
infections among the health care associated and community acquired infections. 
Emergence of Vancomycin resistant enterococci (VRE) poses therapeutic failure and 
increase in the mortality and morbidity. Hence, regular screening and confirmation of 
VRE should be included in the laboratory testing protocol. Stringent infection control 
measures and regular surveillance would help constrain the spread of vancomycin 
resistant enterococci. 
 
Key words: Enterococci , VRE, Biofilm. 
 
